{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:39:48Z","timestamp":1762875588990},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/bf03346273","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T21:57:01Z","timestamp":1396043821000},"page":"807-812","source":"Crossref","is-referenced-by-count":39,"title":["The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region"],"prefix":"10.1007","volume":"27","author":[{"given":"H.","family":"Raef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ingemansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sobhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346273_CR1","first-page":"512","volume-title":"Principles and Practice of Endocrinology and Metabolism","author":"SJ Silverberg","year":"1995","unstructured":"Silverberg SJ, Fitzpatrick LA, Bilezikian JP. Primary hyperthyroidism. In: Becker KL ed. Principles and Practice of Endocrinology and Metabolism. 2nd ed. Philadelphia: J.B. Lippincott Company. 1995, 512\u201320.","edition":"2nd ed."},{"key":"BF03346273_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1995.tb02043.x","volume":"43","author":"CV Harinarayan","year":"1995","unstructured":"Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 1995, 43: 351\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346273_CR3","first-page":"127","volume":"2","author":"NJY Woodhouse","year":"1982","unstructured":"Woodhouse NJY, Norton WL. Low vitamin D levels in Saudi Arabians. King Faisal Specialist Hospital Medical Journal 1982, 2: 127\u201331.","journal-title":"King Faisal Specialist Hospital Medical Journal"},{"key":"BF03346273_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5144\/0256-4947.1999.110","volume":"19","author":"MA Fouda","year":"1999","unstructured":"Fouda MA. Primary hyperparathyroidism: King Khalid University Hospital Experience. Ann Saudi Med 1999, 19: 110\u20135.","journal-title":"Ann Saudi Med"},{"key":"BF03346273_CR5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF01655437","volume":"12","author":"SG Ingemansson","year":"1988","unstructured":"Ingemansson SG, Hugosson CH, Woodhouse NJY. Vitamin D deficiency and hyperparathyroidism with severe bone disease. World J Surg 1988, 12: 517\u201321.","journal-title":"World J Surg"},{"key":"BF03346273_CR6","first-page":"1054","volume":"85","author":"DS Rao","year":"2000","unstructured":"Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000, 85: 1054\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jcem-62-6-1305","volume":"62","author":"J Wortsman","year":"1986","unstructured":"Wortsman J, Haddad JG, Posillico JT, Brown EM. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. J Clin Endocrinol Metab 1986, 62: 1305\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR8","first-page":"715","volume":"76","author":"S Khosla","year":"1993","unstructured":"Khosla S, Ebeling PR, Fireck AF, Burritt MM, Kao PC, Heath H 3rd. Calcium infusion suggests a \u201cset-point\u201d abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 1993, 76: 715\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR9","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/ndt\/14.10.2398","volume":"14","author":"F Malberti","year":"1999","unstructured":"Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transplant 1999, 14: 2398\u2013406.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03346273_CR10","volume-title":"Pathogenesis and etiology of primary hyperparathyroidism","author":"GEH Fuleihan","year":"1997","unstructured":"Fuleihan GEH. Pathogenesis and etiology of primary hyperparathyroidism. UpToDate, Inc. 1997."},{"issue":"Suppl.73","key":"BF03346273_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1523-1755.1999.07310.x","volume":"56","author":"J Silver","year":"1999","unstructured":"Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int 1999, 56 (Suppl. 73): 2\u20137.","journal-title":"Kidney Int"},{"key":"BF03346273_CR12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","volume":"14","author":"F Cetani","year":"1999","unstructured":"Cetani F, Pinchera A, Pardi E, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 1999, 14: 878\u201382.","journal-title":"J Bone Miner Res"},{"key":"BF03346273_CR13","first-page":"1772","volume":"82","author":"T Carling","year":"1997","unstructured":"Carling T, Ridefelt P, Hellman P, Rastad J, Akerstrom G. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 1997, 82: 1772\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR14","first-page":"1690","volume":"84","author":"P Correa","year":"1999","unstructured":"Correa P, Rastad J, Schwarz P, et al. The vitamin D receptor (VDR) start codon polymorphism in primary hyperparathyroidism and parathyroid VDR messenger ribonucleic acid levels. J Clin Endocrinol Metab 1999 84: 1690\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","volume":"53","author":"DS Sudhaker Rao","year":"2000","unstructured":"Sudhaker Rao DS, Han Z-H, Phillips ER, Palnitkar S, Parfitt AM. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol (Oxf) 2000, 53: 373\u201381.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03346273_CR16","first-page":"2000","volume":"85","author":"T Carling","year":"2000","unstructured":"Carling T, Rastad J, Szabo E, Westin G, Akerstrom G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 2000\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346273_CR17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","volume":"56","author":"GA Lumb","year":"1974","unstructured":"Lumb GA, Stanbury SW. Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974, 56: 833\u20139.","journal-title":"Am J Med"},{"key":"BF03346273_CR18","first-page":"305","volume":"13","author":"CR Kleeman","year":"1987","unstructured":"Kleeman CR, Norris K, Coburn JW. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Mineral Electrolyte Metab 1987,13: 305\u201310.","journal-title":"Mineral Electrolyte Metab"},{"key":"BF03346273_CR19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0002-9343(69)90083-7","volume":"46","author":"H Vaishnava","year":"1969","unstructured":"Vaishnava H, Rizvi SNA. Primary hyperparathyroidism associated with nutritional osteomalacia. Am J Med 1969, 46: 640\u20134.","journal-title":"Am J Med"},{"key":"BF03346273_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/bmj.299.6693.236","volume":"299","author":"AH Sultan","year":"1989","unstructured":"Sultan AH, Bruckner FE, Eastwood JB. Association between prolonged dietary vitamin D deficiency and autonomous hyperparathyroidism. Bmj 1989, 299: 236\u20137.","journal-title":"Bmj"},{"key":"BF03346273_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","volume":"107","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999, 107: 561\u20137.","journal-title":"Am J Med"},{"key":"BF03346273_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000181253","volume":"32","author":"M Paillard","year":"1989","unstructured":"Paillard M, Gardin J-P, Borensztein P, Prigent A. Determinants of parathormone secretion in primary hyperparathyroidism. Horm Res 1989, 32: 89\u201392.","journal-title":"Horm Res"},{"key":"BF03346273_CR23","first-page":"332","volume":"15","author":"G Coen","year":"1989","unstructured":"Coen G, Bondatti F, de Matteis A, et al. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment. Miner Electrolyte Metab 1989, 15: 332\u20137.","journal-title":"Miner Electrolyte Metab"},{"key":"BF03346273_CR24","first-page":"158","volume":"45","author":"JP Bilezikian","year":"2000","unstructured":"Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities: New York and Beijing. Int J Fertil Womens Med 2000, 45: 158\u201365.","journal-title":"Int J Fertil Womens Med"},{"key":"BF03346273_CR25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2265.2003.t01-1-01755.x","volume":"59","author":"S Miedlich","year":"2003","unstructured":"Miedlich S, Krohn K, and Paschke R. Update on genetic and clinical aspects of primary hyperparathyroidism. Clinical Endocrinol (Oxf) 2003, 59: 539\u201354.","journal-title":"Clinical Endocrinol (Oxf)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346273\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:17:28Z","timestamp":1565313448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["BF03346273"],"URL":"https:\/\/doi.org\/10.1007\/bf03346273","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}